×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
THE STATE KEY LA... [2]
Faculty of Healt... [1]
Authors
LI PENG [1]
HU YUANJIA [1]
YU HUA [1]
CHEN XIAOJIA [1]
Document Type
Journal article [4]
Date Issued
2023 [2]
2022 [1]
2021 [1]
Language
英語English [4]
Source Publication
Journal of Drug ... [4]
Indexed By
SCIE [4]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer
Journal article
Wang, Yan, Zhang, Chen, Xiao, Meng, Ganesan, Kumar, Gao, Fei, Liu, Qingqing, Ye, Zhen, Sui, Yue, Zhang, Feng, Wei, Kunhua, Wu, Yaobin, Wu, Jianmin, Du, Bing, Xu, Cong, Li, Yan, Li, Peng, Zhang, Jinming, Chen, Jianping. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:
Wang, Yan
;
Zhang, Chen
;
Xiao, Meng
;
Ganesan, Kumar
;
Gao, Fei
; et al.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
12
IF:
4.5
/
4.7
|
Submit date:2023/02/01
Isoliquiritigenin
Zein-phosphatidylcholine Hybrid Nanoparticles
Bioavailability
Triple-negative Breast Cancer
Safe Therapeutic Strategy
Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer
Journal article
Lin, Xiangping, Wang, Qun, Du, Shuang, Guan, Yucheng, Qiu, Jinmei, Chen, Xiaojia, Yuan, Dongsheng, Chen, Tongkai. Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:
Lin, Xiangping
;
Wang, Qun
;
Du, Shuang
;
Guan, Yucheng
;
Qiu, Jinmei
; et al.
Favorite
|
TC[WOS]:
21
TC[Scopus]:
22
IF:
4.5
/
4.7
|
Submit date:2023/02/01
Breast Cancer
Paclitaxel
Curcumin
Co-delivery
Polymeric Nanoparticles
Nf-κb Signaling Pathway
Dry powder inhalers: A patent review
Journal article
Jiawei Wang, Xiangjun Kong, Linfeng Hu, Yuanjia Hu. Dry powder inhalers: A patent review[J]. Journal of Drug Delivery Science and Technology, 2022, 74, 103540.
Authors:
Jiawei Wang
;
Xiangjun Kong
;
Linfeng Hu
;
Yuanjia Hu
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
4.5
/
4.7
|
Submit date:2022/08/02
Active Ingredients
Dry Powder Inhalers
Indications
Inhibitors
Medicaments
Milestone Patents
Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers
Journal article
Ma, Guanglan, Du, Xiao, Zhu, Jianping, Xu, Feng, Yu, Hua, Li, Juan. Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers[J]. Journal of Drug Delivery Science and Technology, 2021, 63(102493).
Authors:
Ma, Guanglan
;
Du, Xiao
;
Zhu, Jianping
;
Xu, Feng
;
Yu, Hua
; et al.
Favorite
|
TC[WOS]:
19
TC[Scopus]:
23
IF:
4.5
/
4.7
|
Submit date:2021/12/08
Liver Cancer
Combination Chemotherapy
Nanomedicine
Micelles
Metastasis